BRAF and thyroid gland undifferentiated (anaplastic) carcinoma: Subbiah Subbiah V V Kreitman Kreitman RJ RJ Wainberg Wainberg ZA ZA Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer J Clin Oncol J Clin Oncol 2018 2018 36 36 7 7 13 13 10.1200/JCO.2017.73.6785 10.1200/JCO.2017.73.6785 supplied-pmid 29072975?